Mortality from cystic fibrosis in Europe: 1994-2010

Pediatric Pulmonology

Volumn 51, Issue 2, 2016, Pages 133-142

  Quintana Gallego, Esther ^a,b   Ruiz Ramos, Miguel ^c   Delgado Pecellin, Isabel ^a   Calero, Carmen ^a,b   Soriano, Joan B ^d   Lopez Campos, Jose Luis ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Salud y Políticas Sociales de Andalucía ^*  (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

cystic fibrosis; epidemiology; mortality

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; CYSTIC FIBROSIS; DEPENDENT VARIABLE; EUROPEAN UNION; FEMALE; GENE MUTATION; HUMAN; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; SEX DIFFERENCE; ADOLESCENT; AGED; CHILD; EPIDEMIOLOGY; EUROPE; INFANT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; EUROPE; EUROPEAN UNION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84955355851     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.23337     Document Type: Article

References (28)

1. Farrell PM,. The prevalence of cystic fibrosis in the European Union. J Cyst Fibros 2008; 7: 450-453.
2. Rommens JM, Iannuzzi MC, Kerem B, et al., Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989; 245: 1059-1065.
3. Salvatore D, Buzzetti R, Baldo E, et al., An overview of international literature from cystic fibrosis registries. Part 4: update 2011. J Cyst Fibros 2012; 11: 480-493.
4. Corey M, Farewell V,. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol 1996; 143: 1007-1017.
5. Quintana-Gallego E, Delgado-Pecellin I, Calero Acuna C,. CFTR protein repair therapy in cystic fibrosis. Arch Bronconeumol 2014; 50: 146-150.
6. Ramalle-Gomara E, Perucha M, Gonzalez MA, Quinones C, Andres J, Posada M,. Cystic fibrosis mortality trends in Spain among infants and young children: 1981-2004. Eur J Epidemiol 2008; 23: 523-529.
7. Dodge JA, Lewis PA, Stanton M, Wilsher J,. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 2007; 29: 522-526.
8. Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B,. Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997; 145: 794-803.
9. Cerda LJ, Valdivia CG, Guiraldes CE, Sanchez DI,. [Cystic fibrosis mortality in Chile between 1997 and 2003]. Rev Med Chil 2008; 136: 157-162.
10. Reid DW, Blizzard CL, Shugg DM, Flowers C, Cash C, Greville HM,. Changes in cystic fibrosis mortality in Australia, 1979-2005. Med J Aust 2011; 195: 392-395.
11. Eurostat. Availabl at http://epp.eurostat.ec.europa.eu/ LAs accessed: February 27, 2014.
12. Lopez-Campos JL, Ruiz-Ramos M, Soriano JB,. Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis. Lancet Respir Med 2014; 2: 54-62.
13. Romeder JM, McWhinnie JR,. Potential years of life lost between ages 1 and 70: an indicator of premature mortality for health planning. Int J Epidemiol 1977; 6: 143-151.
14. Bellis G, Cazes MH, Parant A, et al., Cystic fibrosis mortality trends in France. J Cyst Fibros 2007; 6: 179-186.
15. McCormick J, Mehta G, Olesen HV, et al., Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis. Lancet 2010; 375: 1007-1013.
16. MacKenzie T, Gifford AH, Sabadosa KA, et al., Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the cystic fibrosis foundation patient registry. Ann Intern Med 2014; 161: 233-241.
17. Buzzetti R, Salvatore D, Baldo E, et al., An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis. J Cyst Fibros 2009; 8: 229-237.
18. Hansell AL, Walk JA, Soriano JB,. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 2003; 22: 809-814.
19. Noone PG, Knowles MR,. 'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations. Respir Res 2001; 2: 328-332.
20. De Boeck K, Zolin A, Cuppens H, Olesen HV, Viviani L,. The relative frequency of CFTR mutation classes in European patients with cystic fibrosis. J Cyst Fibros 2014; 13: 403-409.
21. Cano-Serral G, Perez G, Borrell C, Group C,. Comparability between ICD-9 and ICD-10 for the leading causes of death in Spain. Rev Epidemiol Sante Publique 2006; 54: 355-365.
22. Phelan P, Hey E,. Cystic fibrosis mortality in England and Wales and in Victoria, Australia 1976-80. Arch Dis Child 1984; 59: 71-73.
23. Barr HL, Britton J, Smyth AR, Fogarty AW,. Association between socioeconomic status, sex, and age at death from cystic fibrosis in England and Wales (1959 to 2008): cross sectional study. BMJ 2011; 343: d4662.
24. Alicandro G, Frova L, Di Fraia G, Colombo C,. Cystic fibrosis mortality trend in Italy from 1970 to 2011. J Cyst Fibro 2015; 14: 267-274.
25. Harness-Brumley CL, Elliott AC, Rosenbluth DB, Raghavan D, Jain R,. Gender differences in outcomes of patients with cystic fibrosis. J Womens Health (2002) 2014; 23: 1012-1020.
26. Olesen HV, Pressler T, Hjelte L, et al., Gender differences in the Scandinavian cystic fibrosis population. Pediatr Pulmonol 2010; 45: 959-965.
27. Sarles J, Giorgi R, Berthezene P, et al., Neonatal screening for cystic fibrosis: comparing the performances of IRT/DNA and IRT/PAP. J Cyst Fibros 2014; 13: 384-390.
28. Boyle MP, De Boeck K,. A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect. Lancet Respir Med 2013; 1: 158-163.